PROVIDERS AND ALZHEIMER'S CAREGIVERS TOGETHER

这项针对240名非裔美国人和高加索人居家痴呆症患者的随机临床试验考察了旨在以下目的的干预措施的有效性：1)减少照顾者的抑郁和焦虑，改善健康认知；2)减少照顾者提供的非正式护理的小时数；3)减少正式和非正式的护理 两个DYAD成员的卫生服务利用率。二人组将被随机分配到 日常护理、行为护理或强化护理。干预措施将会发生 每周一次，为期八周，在定期安排的熟练养老院护理期间 参观。本试验使用的材料、协议和方法 目前，NINR-NIA资助了关于加强阿尔茨海默氏症的资源的多点研究 照顾者健康(REACH)。它通过研究居家结合的二联体和 建议分析成本结果。

This randomized clinical trial of 240 African American and Caucasian homebound dementia caregiver-care recipient dyads examines the effectiveness of interventions designed to: 1) reduce caregiver depression and anxiety, and improve health perception, 2) reduce the number of hours of informal care provided by the caregiver, and 3) reduce formal and informal health service utilization by both dyad members. Dyads will be randomized to Usual Care, Behavior Care, or Enhanced Care. Interventions will take place weekly for eight weeks during a regularly scheduled skilled nursing home care visit. This trial uses materials, protocols, and methodologies developed in a currently NINR-NIA funded multisite study of Resources to Enhance Alzheimer's Caregiver Health (REACH). It expands this work by studying homebound dyads and proposes to analyze cost outcomes.